{"date":"2026-04-07","count":22,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6550-2026-04-07-2214-o9jske","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-04-07","time":"22:14:47","subject":"公告本公司申請股票上巿時所出具之承諾事項暨其後續執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-04-07 22:14，「公告本公司申請股票上巿時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-04-07-1908-yohk44","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-04-07","time":"19:08:24","subject":"代重要子公司SYNCHEALTH LTD.公告內部稽核主管異動","clause":"第11款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-04-07 19:08，「代重要子公司SYNCHEALTH LTD.公告內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-04-07-1840-1lb081r","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-04-07","time":"18:40:47","subject":"中裕新藥Trogarzo具「孤兒藥」認證與友岸供應鏈優勢，適用美國232條關稅零關稅待遇","clause":"第53款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-04-07 18:40，「中裕新藥Trogarzo具「孤兒藥」認證與友岸供應鏈優勢，適用美國232條關稅零關稅待遇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-04-07-1828-shgexo","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-04-07","time":"18:28:23","subject":"公告本公司董事會決議通過公司章程變更每股面額","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-04-07 18:28，「公告本公司董事會決議通過公司章程變更每股面額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-04-07-1823-wuqmr3","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-04-07","time":"18:23:13","subject":"公告本公司112年度現金增資發行新股暨國內第一次無擔保轉換公司債之資金運用計畫變更","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-04-07 18:23，「公告本公司112年度現金增資發行新股暨國內第一次無擔保轉換公司債之資金運用計畫變更」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-04-07-1753-kr1eht","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-04-07","time":"17:53:08","subject":"公告本公司董事會決議通過投資有價證券","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-04-07 17:53，「公告本公司董事會決議通過投資有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-04-07-1741-1q6ajh6","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-04-07","time":"17:41:46","subject":"本公司董事會決議召開115年股東常會相關事宜(增列承認及討論事項議案及補充其他應敘明事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-04-07 17:41，「本公司董事會決議召開115年股東常會相關事宜(增列承認及討論事項議案及補充其他應敘明事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-04-07-1719-ac89kl","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-04-07","time":"17:19:30","subject":"公告本公司申請股票上櫃轉上市時所出具之承諾事項暨其後續執行情形","clause":"第51款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-04-07 17:19，「公告本公司申請股票上櫃轉上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-04-07-1659-1fp9a6o","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-04-07","time":"16:59:03","subject":"公告本公司訂定115年現金增資認股基準日及相關事宜。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-04-07 16:59，「公告本公司訂定115年現金增資認股基準日及相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-04-07-1604-11wjw0o","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-04-07","time":"16:04:18","subject":"公告本公司董事會決議股利分派","clause":"第31款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-04-07 16:04，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-04-07-1603-p9zyox","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-04-07","time":"16:03:50","subject":"公告本公司董事會決議除息基準日暨現金股利發放日相關事宜","clause":"第31款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-04-07 16:03，「公告本公司董事會決議除息基準日暨現金股利發放日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-04-07-1603-1wt2l8m","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-04-07","time":"16:03:17","subject":"公告本公司董事會決議通過114年度合併財務報表","clause":"第43款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-04-07 16:03，「公告本公司董事會決議通過114年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-04-07-1602-1aoweer","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-04-07","time":"16:02:40","subject":"公告本公司董事會通過公司治理主管任命案","clause":"第11款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-04-07 16:02，「公告本公司董事會通過公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-04-07-1601-1howjn","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-04-07","time":"16:01:27","subject":"公告本公司董事會決議召開115年股東常會","clause":"第32款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-04-07 16:01，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-04-07-1533-8wfrqd","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-04-07","time":"15:33:58","subject":"本公司受邀參加由中國信託證券主辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-04-07 15:33，「本公司受邀參加由中國信託證券主辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-04-07-1514-12ch631","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-04-07","time":"15:14:49","subject":"代本公司重要子公司葡眾企業股份有限公司公告股東會決議變更公司英文名稱","clause":"第51款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-04-07 15:14，「代本公司重要子公司葡眾企業股份有限公司公告股東會決議變更公司英文名稱」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-04-07-1514-silgbx","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-04-07","time":"15:14:07","subject":"代本公司重要子公司葡眾企業股份有限公司公告115年除息基準日","clause":"第14款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-04-07 15:14，「代本公司重要子公司葡眾企業股份有限公司公告115年除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-04-07-1513-126w4ec","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-04-07","time":"15:13:34","subject":"代本公司重要子公司葡眾企業股份有限公司公告115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-04-07 15:13，「代本公司重要子公司葡眾企業股份有限公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-04-07-1505-142x1c5","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-04-07","time":"15:05:18","subject":"公告本公司115年第一季合併財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-04-07 15:05，「公告本公司115年第一季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-04-07-1357-ln4epx","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-07","time":"13:57:36","subject":"公告更正本公司114年度合併財報電子書P.16及iXBRL申報資訊","clause":"第53款","fact_date":"2026-04-07","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-04-07 13:57，「公告更正本公司114年度合併財報電子書P.16及iXBRL申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-04-07-1321-usi1ve","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-04-07","time":"13:21:20","subject":"本公司股票即將終止興櫃交易並轉至臺灣證券交易所上市交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-04-07 13:21，「本公司股票即將終止興櫃交易並轉至臺灣證券交易所上市交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-04-07-0646-8ih4m5","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-04-07","time":"06:46:01","subject":"本公司網路資安事件說明","clause":"第26款","fact_date":"2026-04-02","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-04-07 06:46，「本公司網路資安事件說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}